2014
DOI: 10.1124/dmd.114.061176
|View full text |Cite
|
Sign up to set email alerts
|

Drug-Metabolizing and Antioxidant Enzymes in Monosodium L-Glutamate Obese Mice

Abstract: The prevalence of obesity is rapidly increasing across the world. Physiologic alterations associated with obesity are known to alter enzyme expression and/or activities. As drug-metabolizing and antioxidant enzymes serve as defense system against potentially toxic compounds, their modulation might have serious consequences. In this work, we studied selected antioxidant and drugmetabolizing enzymes (DME) in monosodium glutamate-mouse model of obesity. Specific activities, protein, and mRNA expressions of these … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 14 publications
(4 citation statements)
references
References 69 publications
1
3
0
Order By: Relevance
“…Nrf2, one of the redox-associated transcription factors, is a crucial molecule that regulates antioxidant defense system-related enzymes, such as SODs, HO-1, NQO1, and GPx. , Hence, Nrf2 is regarded as a potential target in the prevention and amelioration of obesity and obesity-derived oxidative stress. In previous reports, the antioxidant defense system was shown to be damaged under obese condition. Our results similarly showed that renal Nrf2 and its related proteins were significantly increased in an obese group. In contrast to protein levels of antioxidant enzymes including MnSOD, total SOD activity in the obesity group was lower than that of the normal group.…”
Section: Discussionsupporting
confidence: 84%
“…Nrf2, one of the redox-associated transcription factors, is a crucial molecule that regulates antioxidant defense system-related enzymes, such as SODs, HO-1, NQO1, and GPx. , Hence, Nrf2 is regarded as a potential target in the prevention and amelioration of obesity and obesity-derived oxidative stress. In previous reports, the antioxidant defense system was shown to be damaged under obese condition. Our results similarly showed that renal Nrf2 and its related proteins were significantly increased in an obese group. In contrast to protein levels of antioxidant enzymes including MnSOD, total SOD activity in the obesity group was lower than that of the normal group.…”
Section: Discussionsupporting
confidence: 84%
“…Elevated activities of drug‐metabolizing enzymes, NAD(P)H:quinone oxidoreductase 1 and UDP‐glucuronosyltransferases 1A, caused alterations in drug pharmacokinetics, in an MSG‐mouse model of obesity (4 mg/g/day, s.c., MSG to newborn mice, in the first 6 days of life, followed by 10 mg/g day in days 7 and 8, and 20 mg/g in days 9 and 10). Moreover, decreased capacity of glutathione S‐transferases, in obese animals, indicated a potentially reduced antioxidant defense and diminished chemoprotection (Dluzen & Lazarus, ; Matouskova et al., ). These enzymes can either inactivate carcinogens or, in some cases, generate reactive species with higher reactivity compared to the original compound.…”
Section: Promotion Of Tumor Development In Msg‐induced Obesitymentioning
confidence: 99%
“…Our in vivo study with non-obese mice, but the same experimental design as in the presented one, showed a different effect of GTE on the activity of NQO (increase), GPx and GST (decrease) . Moreover, this dissimilarity can be connected with the fact that obesity itself altered the activity of these enzymes in comparison to the non-obese rodents [Noeman et al, 2011;Matouskova et al, 2015], which may be caused by elevated expression of Nrf2 in MSG-obese mice . Moreover, the effect of green tea polyphenols on the antioxidant system of rodents is concentration-dependent with high doses (5-10 g/kg of the diet) causing down-regulation of Nrf2-dependent antioxidant enzymes in the liver and kidney [Murakami, 2014].…”
Section: Discussionmentioning
confidence: 99%